Cite
HARVARD Citation
Pereira, M. et al. (n.d.). 21. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results. Open forum infectious diseases. pp. S14-S15. [Online].